The Combination Therapy of Dietary Galacto-Oligosaccharides With Budesonide Reduces Pulmonary Th2 Driving Mediators and Mast Cell Degranulation in a Murine Model of House Dust Mite Induced Asthma. [electronic resource]
Producer: 20190930Description: 2419 p. digitalISSN:- 1664-3224
- Animals
- Anti-Inflammatory Agents -- therapeutic use
- Antigens, Dermatophagoides -- immunology
- Asthma -- therapy
- Budesonide -- therapeutic use
- Cell Degranulation
- Combined Modality Therapy
- Cytokines -- metabolism
- Dietary Supplements
- Disease Models, Animal
- Humans
- Hypersensitivity -- therapy
- Lung -- pathology
- Mast Cells -- immunology
- Mice
- Mice, Inbred BALB C
- Oligosaccharides -- administration & dosage
- Pyroglyphidae -- immunology
- Th1-Th2 Balance
- Th2 Cells -- immunology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.